Although ZDHHC17 and MAP2K4 staining intensities varied among the untreated glioma tissues, ZDHHC17 and MAP2K4 expression tended to increase in recurrent compared to naive tumor sections (4 of 5) (Figure 8G). This evidence concerns the gene ZDHHC17 and central nervous system cancer.